NM_032322.4:c.232C>A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS2_Supporting

The NM_032322.4(RNF135):​c.232C>A​(p.Leu78Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000362 in 1,381,292 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

RNF135
NM_032322.4 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.75

Publications

0 publications found
Variant links:
Genes affected
RNF135 (HGNC:21158): (ring finger protein 135) The protein encoded by this gene contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. This gene is located in a chromosomal region known to be frequently deleted in patients with neurofibromatosis. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
RNF135 Gene-Disease associations (from GenCC):
  • overgrowth-macrocephaly-facial dysmorphism syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • overgrowth syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22555685).
BS2
High AC in GnomAdExome4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNF135NM_032322.4 linkc.232C>A p.Leu78Met missense_variant Exon 1 of 5 ENST00000328381.10 NP_115698.3 Q8IUD6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNF135ENST00000328381.10 linkc.232C>A p.Leu78Met missense_variant Exon 1 of 5 1 NM_032322.4 ENSP00000328340.5 Q8IUD6-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000362
AC:
5
AN:
1381292
Hom.:
0
Cov.:
31
AF XY:
0.00000293
AC XY:
2
AN XY:
681906
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29032
American (AMR)
AF:
0.00
AC:
0
AN:
35142
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24842
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34508
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78356
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42514
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4108
European-Non Finnish (NFE)
AF:
0.00000465
AC:
5
AN:
1075452
Other (OTH)
AF:
0.00
AC:
0
AN:
57338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 22, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.232C>A (p.L78M) alteration is located in exon 1 (coding exon 1) of the RNF135 gene. This alteration results from a C to A substitution at nucleotide position 232, causing the leucine (L) at amino acid position 78 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.49
BayesDel_addAF
Benign
-0.029
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.030
T;T;.;.
Eigen
Benign
0.13
Eigen_PC
Benign
-0.0044
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.65
T;T;T;T
M_CAP
Uncertain
0.086
D
MetaRNN
Benign
0.23
T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.1
M;.;M;M
PhyloP100
1.8
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-1.3
N;N;N;N
REVEL
Benign
0.062
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Uncertain
0.010
D;D;D;D
Polyphen
1.0
D;.;D;.
Vest4
0.20
MutPred
0.41
Gain of MoRF binding (P = 0.0697);Gain of MoRF binding (P = 0.0697);Gain of MoRF binding (P = 0.0697);Gain of MoRF binding (P = 0.0697);
MVP
0.31
MPC
0.30
ClinPred
0.97
D
GERP RS
2.4
PromoterAI
0.0040
Neutral
Varity_R
0.49
gMVP
0.14
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1475624087; hg19: chr17-29298323; API